title: Inhibition and escape of SARS-CoV treated with antisense morpholino oligomers.
authors.affiliation: The Scripps Research Institute, La Jolla, California, USA.
authors.forename: Benjamin W
authors.initials: BW
authors.lastname: Neuman
authors.forename: David A
authors.initials: DA
authors.lastname: Stein
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Kroeker
authors.forename: Hong M
authors.initials: HM
authors.lastname: Moulton
authors.forename: Richard K
authors.initials: RK
authors.lastname: Bestwick
authors.forename: Patrick L
authors.initials: PL
authors.lastname: Iversen
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Buchmeier
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology; D001665:Binding Sites; D006801:Humans; D019590:Nucleocapsid Proteins / Q000378:metabolism; D016376:Oligonucleotides, Antisense / Q000737:chemistry* / Q000235:genetics; D011485:Protein Binding; D045473:Severe acute respiratory syndrome-related coronavirus / Q000235:genetics*; D045169:Severe Acute Respiratory Syndrome / Q000235:genetics* / Q000628:therapy*
chemical_list: D000998:Antiviral Agents; D019590:Nucleocapsid Proteins; D016376:Oligonucleotides, Antisense